Question: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Description: The Chemical can be represented with the SMILES O=C([O-])CCc1nc(-c2ccccc2)c(-c2ccccc2)o1.[K+].
Result: Approved
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
O=C([O-])CCc1nc(-c2ccccc2)c(-c2ccccc2)o1.[K+]
O=C([O-])CCc1nc(-c2ccccc2)c(-c2ccccc2)o1.[K+]
potassium;3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoate
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.